<DOC>
	<DOCNO>NCT00002238</DOCNO>
	<brief_summary>To evaluate safety efficacy interferon beta ( Betaseron ) AIDS advance AIDS relate complex ( ARC ) patient receive reduced-dose zidovudine ( AZT ) regimen .</brief_summary>
	<brief_title>Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate Safety Efficacy Betaseron AIDS Advanced ARC Patients Receiving Reduced-Dose AZT Regimen</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Interferon beta-1b</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Zidovudine ( AZT ) . Patient must : Uninterrupted therapy reduceddose AZT 500 600 mg/day least 3 week entry . Acceptable hepatic renal function . AMENDED delete follow sentence : Hematologic intolerance fulldose zidovudine ( AZT ) ( 1000 1200 mg/day ) . Exclusion Criteria Coexisting Condition : Patients follow exclude : Concurrent , ineffectively control opportunistic infection . Extensive cutaneous and/or visceral Kaposi 's sarcoma require systemic chemotherapy . Proteinuria 2+ great . HIV encephalopathy . HIV waste syndrome . New York Heart Classification III IV . Uncontrolled angina pectoris . Evidence clinically significant , multifocal uncontrolled cardiac dysrhythmias . Concurrent Medication : Excluded : Antiretrovirals zidovudine ( AZT ) Betaseron . Chronic acyclovir therapy . Acetaminophen . Patients follow exclude : Intolerance ( hematologic otherwise ) zidovudine ( AZT ) dose 100 mg orally every 4 hour . AMENDED : Intolerance dose 500 600 mg/day . Medical psychiatric condition compromise patient 's ability give inform consent complete study . Prior Medication : Excluded within 30 day study entry : Cytotoxic chemotherapy . Prior therapy alpha , beta , gamma interferon . Active drug alcohol abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 1991</verification_date>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Zidovudine</keyword>
	<keyword>Interferon Type I</keyword>
</DOC>